OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A tri-specific killer engager against mesothelin targets NK cells towards lung cancer
Philippa R Kennedy, Daniel A. Vallera, Brianna Ettestad, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Philippa R Kennedy, Daniel A. Vallera, Brianna Ettestad, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Showing 15 citing articles:
Natural killer cell-mediated immune surveillance in cancer: Role of tumor microenvironment
Mohamed J. Saadh, Irodakhon Rasulova, Mohammed N. A. Khalil, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155120-155120
Closed Access | Times Cited: 9
Mohamed J. Saadh, Irodakhon Rasulova, Mohammed N. A. Khalil, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155120-155120
Closed Access | Times Cited: 9
Therapeutic approaches to enhance natural killer cell cytotoxicity
Terran Stenger, Jeffrey S. Miller
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Terran Stenger, Jeffrey S. Miller
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Harnessing Natural Killer Cells for Lung Cancer Therapy
Shoubao Ma, Michael A. Caligiuri, Jianhua Yu
Cancer Research (2023) Vol. 83, Iss. 20, pp. 3327-3339
Closed Access | Times Cited: 12
Shoubao Ma, Michael A. Caligiuri, Jianhua Yu
Cancer Research (2023) Vol. 83, Iss. 20, pp. 3327-3339
Closed Access | Times Cited: 12
Multispecific Antibodies Targeting PD-1/PD-L1 in Cancer
Miaomiao Chen, Yuli Zhou, Kelvin K H Bao, et al.
BioDrugs (2025)
Closed Access
Miaomiao Chen, Yuli Zhou, Kelvin K H Bao, et al.
BioDrugs (2025)
Closed Access
Harnessing natural killer cell effector function against cancer
Matthew D. Blunt, Salim I. Khakoo
Immunotherapy Advances (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Matthew D. Blunt, Salim I. Khakoo
Immunotherapy Advances (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Contemporary Approaches to Immunotherapy of Solid Tumors
A. V. Kuznetsova, Ksenia А. Glukhova, О. П. Попова, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2270-2270
Open Access | Times Cited: 3
A. V. Kuznetsova, Ksenia А. Glukhova, О. П. Попова, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2270-2270
Open Access | Times Cited: 3
Advancements and challenges in immunocytokines: A new arsenal against cancer
Wenqiang Shi, Nan Liu, Huili Lu
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 11, pp. 4649-4664
Open Access | Times Cited: 3
Wenqiang Shi, Nan Liu, Huili Lu
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 11, pp. 4649-4664
Open Access | Times Cited: 3
Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments
Philippa R Kennedy, Upasana Sunil Arvindam, Shee Kwan Phung, et al.
Science Advances (2024) Vol. 10, Iss. 44
Open Access | Times Cited: 2
Philippa R Kennedy, Upasana Sunil Arvindam, Shee Kwan Phung, et al.
Science Advances (2024) Vol. 10, Iss. 44
Open Access | Times Cited: 2
Tri-specific killer engager: unleashing multi-synergic power against cancer
Peeranut Winidmanokul, Aussara Panya, Seiji Okada
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 2, pp. 432-448
Open Access | Times Cited: 1
Peeranut Winidmanokul, Aussara Panya, Seiji Okada
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 2, pp. 432-448
Open Access | Times Cited: 1
CD38/NAD+ glycohydrolase and associated antigens in chronic lymphocytic leukaemia: from interconnected signalling pathways to therapeutic strategies
Brigitte Bauvois, Florence Nguyen‐Khac, Hélène Merle‐Béral, et al.
Biochimie (2024)
Closed Access | Times Cited: 1
Brigitte Bauvois, Florence Nguyen‐Khac, Hélène Merle‐Béral, et al.
Biochimie (2024)
Closed Access | Times Cited: 1
Murine models to study human NK cells in human solid tumors
Monica Parodi, Simonetta Astigiano, Paolo Carrega, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Monica Parodi, Simonetta Astigiano, Paolo Carrega, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Natural Killer Cells in Anti-Tumour Immunity
Lara V. Graham, Matthew D. Blunt
Elsevier eBooks (2024)
Closed Access
Lara V. Graham, Matthew D. Blunt
Elsevier eBooks (2024)
Closed Access
Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Enhances Natural Killer Cell Cytotoxicity in HER2-Overexpressing Ovarian Cancer
Sa Deok Hong, Nar Bahadur Katuwal, Min Sil Kang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11733-11733
Open Access
Sa Deok Hong, Nar Bahadur Katuwal, Min Sil Kang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11733-11733
Open Access
Research Progress on Peripheral Blood Biomarkers Based on PD-1/PD-L1 Inhibitors for Advanced Non-Small Cell Lung Cancer
雅楠 苗
Advances in Clinical Medicine (2024) Vol. 14, Iss. 11, pp. 126-133
Closed Access
雅楠 苗
Advances in Clinical Medicine (2024) Vol. 14, Iss. 11, pp. 126-133
Closed Access
Lycopene Promotes NK Cell Cytotoxicity Towards Non-small Cell Lung Carcinoma via Regulating NF-κB Signaling
Yi Guo, Guiwu Lu, Xiong-Yan Xiang, et al.
International Journal of Cancer Management (2024) Vol. 17, Iss. 1
Open Access
Yi Guo, Guiwu Lu, Xiong-Yan Xiang, et al.
International Journal of Cancer Management (2024) Vol. 17, Iss. 1
Open Access
